BCL2L1 and colorectal carcinoma: Consequently the MCL1:BCL-XL ratio was substantially biased towards MCL1 in melanoma (Fig. 1h); the median ratio was 5–6 in melanoma vs. ~1 in CRC and pancreatic tumour cells, and ~2 in NSCLC (Fig. 1h).